Quarterly ResultMay 4, 2026, 04:59 PM
Medifast Q1 Revenue $76.04M, Net Loss $(2.12)M; EPS $(0.19)
AI Summary
Medifast reported a significant decline in Q1 2026 financial results, with revenue falling to $76.04 million and net loss increasing to $2.12 million. The company is executing a strategic transformation, focusing on holistic metabolic health and leveraging its coach-guided lifestyle system. It also completed the sale of its Maryland Distribution Center, generating a $2.2 million gain.
Key Highlights
- Revenue decreased 34.3% to $76.04 million in Q1 2026 from $115.73 million in Q1 2025.
- Net loss increased to $2.12 million in Q1 2026 from $0.77 million in Q1 2025.
- Basic loss per share was $(0.19) in Q1 2026, compared to $(0.07) in Q1 2025.
- Gross profit declined 38.6% to $51.76 million in Q1 2026 from $84.25 million in Q1 2025.
- Cash and cash equivalents were $71.53 million as of March 31, 2026, down from $89.30 million.
- Company sold Maryland Distribution Center for $3.6 million, recognizing a $2.2 million gain.
- Active earning independent coaches were approximately 14,000 for Q1 2026.
- Advertising expense reduced to $0.2 million in Q1 2026 from $4.6 million in Q1 2025.
Price Impact
More from MED